Jiangsu Hengrui Buys Braveheart Shares: A Strong Vote of Confidence in Their Pipeline
Jiangsu Hengrui’s purchase of Braveheart Bio common shares signals deep confidence in its BHB‑1893 pipeline, hinting at stronger future valuations if trials succeed.
2 minutes to read